Mumbai-based biotech startup BacAlt Biosciences has secured Rs 18 crore in funding to scale production of high-performance, sustainable bio-polymers. The round was led by Avaana Capital with participation from Lubrizol InnoVentures, the co-innovation platform of speciality chemicals major Lubrizol.

BacAlt develops bio-based polymers that offer non-microplastic, cost-competitive alternatives to synthetic ingredients, using circular feedstocks and low-energy fermentation methods. The solutions are targeted at mass-market applications in home and personal care, agrochemicals, nutraceuticals, and pharmaceuticals.

The company plans to use the funds to expand R&D, build pilot facilities, strengthen its team, and prepare for international expansion. Co-founder Shruti Kutmutia said BacAlt aims to position India as a hub for sustainable speciality ingredients, while Avaana’s Shruti Srivastava noted the company’s ability to meet the performance and cost thresholds needed for scale. Lubrizol added that the partnership would help accelerate new product development for global markets.